CIK 0001506983 · Non-accelerated filer<br>Smaller reporting company
Glucotrack, Inc.
Sign in to watch- Ticker
- GCTK
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980668934
- Phone
- 972 (8) 675-7878
- Business address
- 301 RT 17 NORTH, SUITE 800, RUTHERFORD, NJ, 07070
- Former names
- Integrity Applications, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-14 | Carter Erin Catherine Director | Conversion | +2,078 | $31.20 | $65K | 3,439 |
| 2024-11-14 | Carter Erin Catherine Director | Conversion · Convertible Promissory Note | +0 | $64,831.00 | $0 | 0 |
| 2024-11-14 | Carter Erin Catherine Director | Grant or award · Series A Common Warrant | +2,078 | 2,078 | ||
| 2024-11-14 | Carter Erin Catherine Director | Grant or award · Series B Common Warrant | +2,078 | 2,078 | ||
| 2024-11-14 | Goode Paul Chief Executive Officer | Conversion | +796 | $31.20 | $25K | 2,054 |
| 2024-11-14 | Goode Paul Chief Executive Officer | Conversion · Convertible Promissory Note | −0 | $24,831.00 | $0 | |
| 2024-11-14 | Goode Paul Chief Executive Officer | Grant or award · Series A Common Warrant | +796 | 796 | ||
| 2024-11-14 | Goode Paul Chief Executive Officer | Grant or award · Series B Common Warrant | +796 | 796 | ||
| 2024-07-30 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Purchase · Warrants to Purchase Common Stock | +106,667 | 106,667 | ||
| 2024-07-30 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Purchase · Warrants to Purchase Common Stock | +76,191 | 76,191 | ||
| 2024-07-30 | John A. Ballantyne Revocable Living Trust dated 08/01/2017 10% owner | Purchase · Warrants to Purchase Common Stock | +59,260 | 59,260 | ||
| 2024-07-30 | BALLANTYNE JOHN Director | Purchase · Warrants to Purchase Common Stock | +106,667 | 106,667 | ||
| 2024-07-30 | BALLANTYNE JOHN Director | Purchase · Warrants to Purchase Common Stock | +76,191 | 76,191 | ||
| 2024-07-30 | BALLANTYNE JOHN Director | Purchase · Warrants to Purchase Common Stock | +59,260 | 59,260 | ||
| 2024-07-18 | Malave Luis Director | Purchase · Convertible Promissory Note | +0 | $200,000.00 | $0 | |
| 2024-07-18 | Carter Erin Catherine Director | Purchase · Convertible Promissory Note | +0 | $50,000.00 | $0 | |
| 2024-07-18 | Goode Paul Chief Executive Officer | Purchase · Convertible Promissory Note | +0 | $10,000.00 | $0 | |
| 2024-07-01 | Goode Paul Chief Executive Officer | Purchase · Warrants to Purchase Common Stock | +2,100 | 2,100 | ||
| 2024-07-01 | SYCOFF DREW Director | Purchase · Warrants to Purchase Common Stock | +138,000 | 138,000 | ||
| 2024-07-01 | Goode Paul Chief Executive Officer | Purchase · Warrants to Purchase Common Stock | +42,000 | 42,000 |
Page 3 of 6 · 115 trades